Synthpop has secured $15 million in Series A financing led by Ansa Capital, bringing its total funding to $23 million. Strategic investors in the round include former Humana CEO Bruce Broussard. The funding supports Synthpop’s efforts to expand an agentic AI platform designed to automate some of healthcare’s most complex and resource-intensive administrative tasks.
The company is positioning itself beyond traditional generative AI tools by focusing on what it describes as “agentic” automation—systems that do not simply generate text, but execute multi-step workflows end to end. Healthcare administration often requires navigating non-linear processes, such as reviewing clinical documentation, interpreting payer-specific rules, and engaging in follow-up communications. Synthpop’s platform combines document intelligence, payer-aware reasoning, and conversational voice agents into a coordinated system capable of handling these demands.
Synthpop’s agents integrate directly with electronic health records and billing platforms, allowing them to manage referrals, eligibility checks, prior authorizations, and claims follow-ups within existing provider workflows. To strengthen its technical foundation, the company recently acquired the team behind airt, led by Davor Runje and Hajdi Cenan, both contributors to Microsoft’s AutoGen framework. The acquisition reflects a focus on building scalable multi-agent infrastructure rather than point solutions.
“Point solutions can’t fix operational bottlenecks,” said Elad Ferber, CEO of Synthpop. “Providers need a unified system that understands insurance requirements… and works seamlessly with their existing software.”
The economic case for adoption is centered on efficiency gains. According to Synthpop, administrative workflows that historically required approximately 40 minutes of staff time are now completed in under one minute using its platform. The company reports that automated processes operate at a cost five times lower than traditional human labor. To date, the platform has been used across workflows involving more than 2 million patients and has integrated with eight major EHR systems.
In the context of persistent staffing shortages and rising administrative expenses, investors see agentic AI as a structural shift. “Healthcare organizations have long been constrained by highly manual workflows,” said Marco DeMeireles, Co-Founder & Managing Partner at Ansa Capital, who is joining the Synthpop board. “AI-native solutions like Synthpop are the only way for them to fulfill rising demand.”
Click here for the original news story.